Jinhai Medical Technology Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-106.00
-18.00
4.00
0.00
8.00
0.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-12.00
-20.00
-2.00
-6.00
25.00
13.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-21.00
-10.00
26.00
19.00
39.00
46.00
Cash Flow from Investing Activities
-53.00
-39.00
-7.00
-16.00
-34.00
13.00
Cash Flow from Financing Activities
19.00
80.00
-21.00
-27.00
-21.00
-27.00
Net Cash Inflow / Outflow
-56.00
28.00
-4.00
-23.00
-17.00
32.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-1.00
-2.00
-1.00
0.00
-1.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Jinhai Medical Technology Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-106.422856478998
205.037570856011
-311.00
-151.90%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-12.2321766787459
-188.302575846956
176.00
93.50%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-21.8369168393841
158.296681005645
-179.00
-113.79%
Cash Flow from Investing Activities
-53.0567014223216
134.290880908755
-187.00
-139.51%
Cash Flow from Financing Activities
19.1919640778223
-138.068316776041
157.00
113.90%
Net Cash Inflow / Outflow
-56.927791225667
155.587205623227
-211.00
-136.59%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-1.2261370417836
1.06796048486686
-2.00
-214.81%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -111.42% vs -139.52% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-21.84
-10.33
-111.42%






